AI-based Platform for Automated Genomic Interpretation
Emedgene is a genomics intelligence platform that uses natural language processing to digest new genetic publications and incorporate them into an always-up-to-date knowledge base. It then runs machine-learning discovery algorithms to pinpoint pathogenic variants for a clear path to clinical decisions. Clinical labs using Emedgene can improve dry lab efficiency, reduce time spent on interpretation and reporting, increase yield, and scale up their genomic interpretation operation. Research organizations using Emedgene can accelerate genomic-driven discovery through the application of end-to-end artificial intelligence, from natural language processing of publications through custom machine-learning algorithms. Emedgene aims to help geneticists and clinicians understand the clinical meaning of unique genetic variants so that they can provide their patients with personalized care.
| Name | Emedgene |
|---|---|
| Slug | emedgene |
| Type / kind | startup |
| Crunchbase ID | emedgene |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgI_4scoJDA |
| Status | inactive |
|---|---|
| Status reason | Acquired (Inactive) by Illumina on Dec 2021 - closed due to acquisition |
| Last update | 2026-05-17 |
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Tel Aviv-Yafo |
| HQ address | Yigal Alon 55A, Tel Aviv-Yafo, Israel |
| https://www.linkedin.com/company/10391591 | |
| Twitter / X | https://twitter.com/emedgene |
| https://www.facebook.com/emedgene | |
| YouTube | https://www.youtube.com/channel/UCUSPMpmk8IDvztYqMsZIvOA |
| Total raised | $6.0M |
|---|---|
| Current stage | Acquired |
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}